California Attorney General unveils new legislation that is aimed at curbing increasing drug prices.

This Weekly’s Hot Topics

  • California Attorney General unveils new legislation that is aimed at curbing increasing drug prices. (California News)
  • Executives from seven Big Pharma companies will meet with Senate Finance Committee. (National News)
  • CMS Interoperability and Patient Access Proposed Rule Listening Session March 5. (CMS News)

California Attorney General Xavier Becerra and California Assembly Member Jim Wood held a press conference to unveil new legislation that they say is aimed at curbing increasing drug prices. The bill will prohibit “collusive agreements in which a drug company transfers anything of value to delay a competitor’s research, marketing, or sale of a competing version of its drug.” To read more click here and go to California News.

MOASC is looking for feedback from members regarding individual instances of copay accumulator use in California. Specific information needed are the names of the healthplans, group numbers (if applicable), PBMs and employers, with just your contact information. The information you provide would go a long way in helping patient and provider advocacy groups and organizations like MOASC & ANCO to fight to limit their use. To read more click here and go to MOASC News.

More than a quarter of physicians (28%) report that the prior authorization process required by health insurers for certain drugs, tests and treatments have led to serious or life-threatening events for their patients according to a new survey by the American Medical Association. To read more click here and go to National News.

To read the complete California Oncology Weekly Newsletter, click on the date below.

February 26, 2019



No comments have been posted yet.